Related Experiment Video
Updated: Jan 25, 2026
12:40
A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
2.1K
Butorphanol in Labour Analgesia.
Jyotsna Yadav1, Mohan Chandra Regmi1, Pritha Basnet1
1Department of Obstetrics and Gyecology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
JNMA; Journal of the Nepal Medical Association
|May 9, 2019
Summary
Butorphanol injection effectively reduced labor pain in women. This study found it to be a safe option for pain relief during childbirth with no significant adverse effects on newborns.
Area of Science:
- Obstetrics and Gynecology
- Pain Management
- Pharmacology
Background:
- Labor pain is a severe physiological and psychological experience for many women.
- Fear of labor pain can deter women from choosing natural delivery.
- Various pharmacological and non-pharmacological methods are used for labor pain relief.
Purpose of the Study:
- To evaluate the efficacy of butorphanol injection for managing labor pain.
- To assess the safety and impact of butorphanol on maternal and neonatal outcomes.
Main Methods:
- A descriptive cross-sectional study involving 200 pregnant women.
- Butorphanol (1 mg intramuscular) administered at the active stage of labor.
- Pain assessment using the Numerical Pain Analogue Scale (1-10).
- Monitoring of fetal heart rate and neonatal Apgar scores.
Main Results:
- Pain scores were recorded in the first four hours post-administration.
- Statistically significant pain reduction was observed in the first and second hours.
- No significant adverse effects were noted in mothers or neonates.
Conclusions:
- Butorphanol serves as an effective analgesic for labor pain.
- It demonstrates a favorable safety profile for both mother and neonate.
- Butorphanol is a viable option for labor analgesia.
